For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was $6.84 for the day, down -3.93% from the previous closing price of $7.12. In other words, the price has decreased by -$3.93 from its previous closing price. On the day, 0.61 million shares were traded. AUPH stock price reached its highest trading level at $7.14 during the session, while it also had its lowest trading level at $6.83.
Ratios:
Our analysis of AUPH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 5.33. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.19.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 06 ’24 when Habig Scott Michael sold 18,249 shares for $5.31 per share. The transaction valued at 96,902 led to the insider holds 456,338 shares of the business.
Balakrishnan Brinda sold 520 shares of AUPH for $2,985 on May 21 ’24. The Director now owns 17,523 shares after completing the transaction at $5.74 per share. On May 21 ’24, another insider, Billen Daniel, who serves as the Director of the company, sold 5,252 shares for $5.74 each. As a result, the insider received 30,146 and left with 28,141 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUPH now has a Market Capitalization of 978058496 and an Enterprise Value of 733708288. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.72 while its Price-to-Book (P/B) ratio in mrq is 2.68. Its current Enterprise Value per Revenue stands at 3.543 whereas that against EBITDA is -27.027.
Stock Price History:
The Beta on a monthly basis for AUPH is 1.46, which has changed by -0.045576394 over the last 52 weeks, in comparison to a change of 0.3069358 over the same period for the S&P500. Over the past 52 weeks, AUPH has reached a high of $10.05, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is 5.31%, while the 200-Day Moving Average is calculated to be 9.91%.
Shares Statistics:
AUPH traded an average of 1.40M shares per day over the past three months and 933900 shares per day over the past ten days. A total of 143.83M shares are outstanding, with a floating share count of 128.68M. Insiders hold about 10.01% of the company’s shares, while institutions hold 40.45% stake in the company. Shares short for AUPH as of 1726185600 were 7579493 with a Short Ratio of 5.40, compared to 1723680000 on 8479709. Therefore, it implies a Short% of Shares Outstanding of 7579493 and a Short% of Float of 5.33.
